The New Palgrave Dictionary of Economics

2018 Edition
| Editors: Macmillan Publishers Ltd

Statistical Analysis of Clinical Trial Data for Resource Allocation Decisions

  • Rita Faria
  • Andrea Manca
Reference work entry
DOI: https://doi.org/10.1057/978-1-349-95189-5_2868

Abstract

Randomised controlled trials (RCTs) are a major source of individual patient level data (IPD) on the clinical outcomes, costs and other measures of health consequences associated with alternative healthcare interventions. These data are typically used to establish the ‘value for money’ of healthcare technologies. While a clear policy framework to guide the above assessment exists, the analysis of RCT data to inform decision making requires the adoption of a specific quantitative methodological framework. This article describes the use of RCTs for cost-effectiveness analysis, discusses the major statistical issues and possible solutions, and outlines recent research developments in this area.

Keywords

Randomised clinical trial Economic evaluation Econometrics Cost-effectiveness 

JEL Classification

C10 D61 I18 I10 
This is a preview of subscription content, log in to check access.

Bibliography

  1. Ades, A.E., M. Sculpher, A. Sutton, K. Abrams, N. Cooper, N. Welton, and G. Lu. 2006. Bayesian methods for evidence synthesis in cost-effectiveness analysis. PharmacoEconomics 24: 1–19.CrossRefGoogle Scholar
  2. Angrist, J.D. 2012. Treatment effect. In The new Palgrave dictionary of economics, ed. S.N. Durlauf and L.E. Blume. Basingstoke: Palgrave Macmillan.Google Scholar
  3. Austin, P.C. 2002. A comparison of methods for analyzing health-related quality-of-life measures. Value in Health 5: 329–337.CrossRefGoogle Scholar
  4. Austin, P.C., M. Escobar, and J.A. Kopec. 2000. The use of the Tobit model for analyzing measures of health status. Quality of Life Research 9: 901–910.CrossRefGoogle Scholar
  5. Basu, A. 2011. Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care. Journal of Health Economics 30(3): 549–559.CrossRefGoogle Scholar
  6. Basu, A., and P.J. Rathouz. 2005. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics 6: 93–109.CrossRefGoogle Scholar
  7. Basu, A., and D. Meltzer. 2007. Value of information on preference heterogeneity and individualized care. Medical Decision Making 27: 112–127.CrossRefGoogle Scholar
  8. Basu, A., and A. Manca. 2012. Regression estimators for generic health-related quality of life and quality-adjusted life years. Medical Decision Making 32: 56–69.CrossRefGoogle Scholar
  9. Black, W.C. 1990. The CE plane. Medical Decision Making 10: 212–214.CrossRefGoogle Scholar
  10. Box, G.E.P., and D.R. Cox. 1964. An analysis of transformations. Journal of the Royal Statistical Society: Series B: Methodological 26(2): 211–252.Google Scholar
  11. Briggs, A.H., D.E. Wonderling, and C.Z. Mooney. 1997. Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Economics 6: 327–340.CrossRefGoogle Scholar
  12. Briggs, A.H., C.Z. Mooney, and D.E. Wonderling. 1999. Constructing confidence intervals for cost-effectiveness ratios: An evaluation of parametric and non-parametric techniques using Monte Carlo simulation. Statistics in Medicine 18: 3245–3262.CrossRefGoogle Scholar
  13. Briggs, A., R. Nixon, S. Dixon, and S. Thompson. 2005. Parametric modelling of cost data: Some simulation evidence. Health Economics 14: 421–428.CrossRefGoogle Scholar
  14. Briggs, A.H., K. Claxton, and M. Sculpher. 2006. Decision modelling for health economic evaluation. Oxford: Oxford University Press.Google Scholar
  15. Buntin, M.B., and A.M. Zaslavsky. 2004. Too much ado about two-part models and transformation?: Comparing methods of modeling Medicare expenditures. Journal of Health Economics 23: 525–542.CrossRefGoogle Scholar
  16. Chib, S. 2008. Markov chain Monte Carlo methods. In The new Palgrave dictionary of economics, ed. S.N. Durlauf and L.E. Blume. Basingstoke: Palgrave Macmillan.Google Scholar
  17. Coyle, D., M.J. Buxton, and B.J. O’Brien. 2003. Stratified cost-effectiveness analysis: A framework for establishing efficient limited use criteria. Health Economics 12: 421–427.CrossRefGoogle Scholar
  18. Dolan, P. 2000. The measurement of health-related quality of life for use in resource allocation in health care. In Handbook of health economics, ed. A Culyer and J. Newhouse. Amsterdam: Elsevier.Google Scholar
  19. Drummond, M.F., M.J. Sculpher, and G.W. Torrance. 2005. Methods for the economic evaluation of health care programmes. New York: Oxford University Press.Google Scholar
  20. Fenwick, E., K. Claxton, and M. Sculpher. 2001. Representing uncertainty: The role of cost-effectiveness acceptability curves. Health Economics 10: 779–787.CrossRefGoogle Scholar
  21. Fenwick, E., B.J. O’Brien, and A. Briggs. 2004. Cost-effectiveness acceptability curves – Facts, fallacies and frequently asked questions. Health Economics 13: 405–415.CrossRefGoogle Scholar
  22. Gold, M.R., J.E. Siegel, L.B. Russell, and M.C. Weinstein. 1996. Cost-effectiveness in health and medicine. New York: Oxford University Press.Google Scholar
  23. Griffin, S.C., J.A. Barber, A. Manca, M.J. Sculpher, S.G. Thompson, M.J. Buxton, and H. Hemingway. 2007. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: Prospective observational study. British Medical Journal 334: 624.CrossRefGoogle Scholar
  24. Hernandez Alava, M., A.J. Wailoo, and R. Ara. 2012. Tails from the peak district: Adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. Value in Health 15: 550–561.CrossRefGoogle Scholar
  25. Hoch, J.S., A.H. Briggs, and A.R. Willan. 2002. Something old, something new, something borrowed, something blue: A framework for the marriage of health econometrics and cost-effectiveness analysis. Health Economics 11: 415–430.CrossRefGoogle Scholar
  26. Huang, I., C. Frangakis, M.J. Atkinson, R.J. Willke, W.L. Leite, W.B. Vogel, and A.W. Wu. 2008. Addressing ceiling effects in health status measures: A comparison of techniques applied to measures for people with HIV disease. Health Services Research 43: 327–339.CrossRefGoogle Scholar
  27. Jones, A.M. 2010. Models for health care. York: Centre for Health Economics, University of York.Google Scholar
  28. Jones, A.M. 2012. Health econometrics. In The new Palgrave dictionary of economics, ed. S.N. Durlauf and L.E. Blume. Basingstoke: Palgrave Macmillan.Google Scholar
  29. Keene, O.N. 2007. The log transformation is special. Statistics in Medicine 14: 811–819.CrossRefGoogle Scholar
  30. Kihlberg, J.K., J.H. Herson, and W.E. Schotz. 1972. Square root transformation revisited. Applied Statistics 21: 76–81.CrossRefGoogle Scholar
  31. Lindsay, B.G., and M. Stewart. 2008. Mixture models. In The new Palgrave dictionary of economics, ed. S.N. Durlauf and L.E. Blume. Basingstoke: Palgrave Macmillan.Google Scholar
  32. Lu, G., and A.E. Ades. 2004. Combination of direct and indirect evidence in mixed treatment comparisons. Statistical Medicine 23: 3105–3124.CrossRefGoogle Scholar
  33. Manca, A., N. Hawkins, and M.J. Sculpher. 2005a. Estimating mean QALYs in trial-based cost-effectiveness analysis: The importance of controlling for baseline utility. Health Economics 14: 487–496.CrossRefGoogle Scholar
  34. Manca, A., N. Rice, M.J. Sculpher, and A.H. Briggs. 2005b. Assessing generalisability by location in trial-based cost-effectiveness analysis: The use of multilevel models. Health Economics 14: 471–485.CrossRefGoogle Scholar
  35. Manca, A., and A.R. Willan. 2006. ‘Lost in translation’: Accounting for between-country differences in the analysis of multinational cost-effectiveness data. PharmacoEconomics 24: 1101.CrossRefGoogle Scholar
  36. Matthews, J.N.S. 2006. Introduction to randomized controlled clinical trials. London: Chapman & Hall/CRC.CrossRefGoogle Scholar
  37. McKenna, C., and K. Claxton. 2011. Addressing adoption and research design decisions simultaneously. Medical Decision Making 31: 853–865.CrossRefGoogle Scholar
  38. Mihaylova, B., A. Briggs, A. O’Hagan, and S.G. Thompson. 2011. Review of statistical methods for analysing healthcare resources and costs. Health Economics 20: 897–916.CrossRefGoogle Scholar
  39. Mullahy, J. 1998. Much ado about two: Reconsidering retransformation and the two-part model in health econometrics. Journal of Health Economics 17: 247–281.CrossRefGoogle Scholar
  40. Nelder, J.A., and R.W.M. Wedderburn. 1972. Generalized linear models. Journal of the Royal Statistical Society, Series A (General) 135(3): 370–384.CrossRefGoogle Scholar
  41. Nixon, R.M., and S.G. Thompson. 2005. Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations. Health Economics 14: 1217–1229.CrossRefGoogle Scholar
  42. Polsky, D., H.A. Glick, R. Willke, and K. Schulman. 1997. Confidence intervals for cost-effectiveness ratios: A comparison of four methods. Health Economics 6: 243–252.CrossRefGoogle Scholar
  43. Powell, J.L. 2008. Semiparametric estimation. In The new Palgrave dictionary of economics, ed. S.N. Durlauf and L.E. Blume. Basingstoke: Palgrave Macmillan.Google Scholar
  44. Pullenayegum, E.M., Wong, H.S., and A. Childs. 2012. Generalized additive models for the analysis of EQ-5D utility data. Medical Decision Making (in press).Google Scholar
  45. Quinn, C. 2007. The health-economic applications of copulas: Methods in applied econometric research. Health, Econometrics and Data Group (HEDG) Working Paper, 7, 22.Google Scholar
  46. Rabin, R., and F. Charro. 2001. EQ-SD: A measure of health status from the EuroQol Group. Annals of Medicine 33: 337–343.CrossRefGoogle Scholar
  47. Robin, J.-M. 2008. Tobit model. In The new Palgrave dictionary of economics, ed. S.N. Durlauf and L.E. Blume. Basingstoke: Palgrave Macmillan.Google Scholar
  48. Saramago, P., A.J. Sutton, N.J. Cooper, and A. Manca. 2012. Mixed treatment comparisons using aggregate and individual participant level data. Statistics in Medicine 31(28): 3516–3536.CrossRefGoogle Scholar
  49. Sculpher, M. 2008. Subgroups and heterogeneity in cost-effectiveness analysis. PharmacoEconomics 26: 799–806.CrossRefGoogle Scholar
  50. Sculpher, M.J., K. Claxton, M. Drummond, and C. McCabe. 2006. Whither trial-based economic evaluation for health care decision making? Health Economics 15: 677–687.CrossRefGoogle Scholar
  51. Sekhon, J.S., and R.D. Grieve. 2011. A matching method for improving covariate balance in cost-effectiveness analyses. Health Economics 21: 695–714.CrossRefGoogle Scholar
  52. Stinnett, A.A., and J. Mullahy. 1998. Net health benefits. Medical Decision Making 18: S68–S80.CrossRefGoogle Scholar
  53. Sutton, A.J., K.R. Abrams, A.E. Ades, N.J. Cooper, and N.J. Welton. 2012. Evidence synthesis for decision making in healthcare. Chichester: Wiley.Google Scholar
  54. Tambour, M., N. Zethraeus, and M. Johannesson. 1998. A note on confidence intervals in cost-effectiveness analysis. International Journal of Technology Assessment in Health Care 14: 467–471.CrossRefGoogle Scholar
  55. Thompson, S.G., and J.A. Barber. 2000. How should cost data in pragmatic randomised trials be analysed? British Medical Journal 320: 1197.CrossRefGoogle Scholar
  56. Torrance, G.W., D.H. Feeny, W.J. Furlong, R.D. Barr, Y. Zhang, and Q. Wang. 1996. Multiattribute utility function for a comprehensive health status classification system: Health Utilities Index Mark 2. Medical Care 34: 702.CrossRefGoogle Scholar
  57. Trivedi, P.K. 2008. Copulas. In The new Palgrave dictionary of economics, ed. S.N. Durlauf and L.E. Blume. Basingstoke: Palgrave Macmillan.Google Scholar
  58. Trivedi, P.K., and D.M. Zimmer. 2005. Copula modeling: An introduction for practitioners. Foundations and Trends in Econometrics 1: 1–111.CrossRefGoogle Scholar
  59. Tunis, S.R., D.B. Stryer, and C.M. Clancy. 2003. Practical clinical trials. Journal of the American Medical Association 290: 1624–1632.Google Scholar
  60. Van Hout, B.A., M.J. Al, G.S. Gordon, and F.F.H. Rutten. 1994. Costs, effects and c/e-ratios alongside a clinical trial. Health Economics 3: 309–319.CrossRefGoogle Scholar
  61. Vanness, D.J., and J. Mullahy. 2012. Perspectives on mean-based evaluation of health care. In The elgar companion to health economics, ed. A.M. Jones. Cheltenham: Edward Elgar.Google Scholar
  62. Willan, A.R., A.H. Briggs, and J.S. Hoch. 2004. Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. Health Economics 13: 461–475.CrossRefGoogle Scholar
  63. Zellner, A., and D.S. Huang. 1962. Further properties of efficient estimators for seemingly unrelated regression equations. International Economic Review 3: 300–313.CrossRefGoogle Scholar

Copyright information

© Macmillan Publishers Ltd. 2018

Authors and Affiliations

  • Rita Faria
    • 1
  • Andrea Manca
    • 1
  1. 1.